Subscribe to stay informed!
Malvern-based Venatorx Pharmaceuticals was awarded a federal BioShield contract by the Biomedical Advanced Research and Development Authority that could net the antibiotics company up…
An Exton-based pharmaceutical company is making a major acquisition after facing hurdles. Its lead program could not continue into its late-stage trial, due…
A medical device company from Malvern has raised $2.5 million for a groundbreaking heart surgery technology. Excision Inc. aims to use the ‘leaflet modification…
Malvern-based NeuroStar, a medical technology company, has expanded to Charlotte, where it has opened a secondary office and training facility, writes Elise Franco for…
Malvern-based Baudax Bio is selling a little over 11.8 million shares of its common stock in a public stock offering that is expected…
Wayne-based Teleflex has entered into an agreement to acquire Ohio-based Standard Bariatrics in a deal valued at up to $300 million, writes John…
Endo International, with North American headquarters in Malvern, filed for bankruptcy last week, yet it has been revealed that $55.5 million in bonuses were…
Malvern-based Tela Bio, a medical technology company that focuses on soft-tissue reconstruction products, is expected to raise $32 million in a public stock…
After struggling with the debt incurred due to opioid litigation settlements, Endo International, the Ireland-based pharmaceutical company with U.S. headquarters in Malvern, has…
West Chester-based Verrica Pharmaceuticals has received a trigger payment of $8 million from its product development partner in Japan after a provision from their…
Exelixis Inc., a Calif. biotech company, targeted King of Prussia to hold its East Coast operations. However, absent a building it found suitable, it is…
Teva Pharmaceutical Industries, an Israel-based company with operations in West Chester, saw its stock surge after announcing it has reached a tentative nationwide settlement…
Endo International, the Dublin-based pharmaceutical company with its U.S. headquarters in Malvern, recently disclosed in a filing with the SEC that it will…
West Chester-based Verrica Pharmaceuticals has moved closer to getting a second chance at approval for its skin disorder drug, writes John George for the…
Berwyn-based Virpax Pharmaceuticals has decided to take the over-the-counter route toward regulatory approval for Epoladerm, its experimental pain treatment for osteoarthritis, writes…
Before we send you to this site, please subscribe to our daily newsletter.